Filing Details

Accession Number:
0001209191-22-004799
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-25 16:36:59
Reporting Period:
2022-01-24
Accepted Time:
2022-01-25 16:36:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Albireo Pharma Inc. ALBO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1213040 J. Martha Carter C/O Albireo Pharma, Inc.
10 Post Office Square, Suite 1000
Boston MA 02109
Chief Regulatory Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-24 423 $24.52 15,877 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.4937 to $24.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. Represents 952 shares of common stock and 14,925 restricted stock units.